Pharmaceutical

STAT+: Gene therapy makers wonder if they can make a profit in Europe. Patients fear being left behind — again

STAT+: Gene therapy makers wonder if they can make a pr...

Oct 4, 2023

In Europe, pricey, likely life-changing treatments are colliding with cost-consc...

Opinion: The case against age limits for politicians

Opinion: The case against age limits for politicians

Oct 4, 2023

Conflating age and health or age and ability cannot actually help us discern who...

Opinion: Listen: How two abortion providers grapple with their post-Roe reality

Opinion: Listen: How two abortion providers grapple wit...

Oct 4, 2023

The frustrating and heartbreaking consequences of living in a post-Roe America f...

STAT+: Colombia set to issue a compulsory license for an HIV medicine sold by GSK’s ViiV

STAT+: Colombia set to issue a compulsory license for a...

Oct 4, 2023

Colombian authorities are set to issue a compulsory license for a needed HIV tre...

FDA authorizes Novavax’s updated Covid-19 vaccine

FDA authorizes Novavax’s updated Covid-19 vaccine

Oct 4, 2023

The FDA on Tuesday authorized Novavax’s updated Covid-19 vaccine, giving America...

STAT+: FDA finds ‘potential systemic bias’ in Amgen’s KRAS drug trial ahead of advisory meeting

STAT+: FDA finds ‘potential systemic bias’ in Amgen’s K...

Oct 4, 2023

A follow-up study of a first-of-its-kind cancer treatment may reflect systemic b...

When is a Wall Street disappointment ‘good enough’ for the FDA?

When is a Wall Street disappointment ‘good enough’ for ...

Oct 4, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Drugmakers agree to negotiate Medicare prices under protest; AstraZeneca settles lawsuits over heartburn drugs

STAT+: Pharmalittle: Drugmakers agree to negotiate Medi...

Oct 4, 2023

Makers of all 10 prescription medicines subject to the first-ever price negotiat...

CT-080 by First Condor Group for Gastric Cancer: Likeli...

Oct 3, 2023

CT-080 is under clinical development by First Condor Group and currently in Phas...

CT-080 by First Condor Group for Solid Tumor: Likelihoo...

Oct 3, 2023

CT-080 is under clinical development by First Condor Group and currently in Phas...

BW-20507 by Argo Biopharma Australia for Hepatitis B: L...

Oct 3, 2023

BW-20507 is under clinical development by Argo Biopharma Australia and currently...

CT-080 by First Condor Group for Esophageal Cancer: Lik...

Oct 3, 2023

CT-080 is under clinical development by First Condor Group and currently in Phas...

BGBA-3055 by BeiGene for Solid Tumor: Likelihood of App...

Oct 3, 2023

BGBA-3055 is under clinical development by BeiGene and currently in Phase I for ...

BGB-26808 by BeiGene for Solid Tumor: Likelihood of App...

Oct 3, 2023

BGB-26808 is under clinical development by BeiGene and currently in Phase I for ...

MC-232 by MC2 Therapeutics for Hidradenitis Suppurativa...

Oct 3, 2023

MC-232 is under clinical development by MC2 Therapeutics and currently in Phase ...

CD123-targeted CAR-NK by Chongqing Precision Biotech fo...

Oct 3, 2023

CD123-targeted CAR-NK is under clinical development by Chongqing Precision Biote...